Anıl Gök
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anıl Gök has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Leman Tekin Orgun
Department of Pediatric Neurology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey
7 shared publications - Bülent Kara
Division of Child Neurology, Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye
6 shared publications - Ayfer Sakarya Güneş
Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
5 shared publications - Gökçe Cırdı
Department of Pediatric Neurology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey
3 shared publications - Adnan Deniz
Department of Pediatric Neurology, Faculty of Medicine, Kocaeli University, 41001 Kocaeli, Türkiye
2 shared publications Bülent Kara
2 shared publications
Latest Publications
- Open Access
- 24 October 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (5) , 882-888
Perineal dysmorphism and patellar luxation in SLC35A2-CDG: a new piece in the glycosylation puzzle
Background. Congenital disorders of glycosylation (CDG) represent a group of inherited metabolic diseases characterized by multisystem involvement. SLC35A2-CDG (OMIM #300896) is a rare X-linked subtype resulting from pathogenic variants in the SLC35A2 gene, which encodes the UDP-galactose transporter. Approximately 70 cases have been documented, predominantly presenting with early-onset epilepsy, developmental delay, hypotonia, and dysmorphic features. Phenotypic variability remains incompletely characterized, and novel features continue to expand the clinical spectrum. Case Presentation. We report a 6-year-old girl with SLC35A2-CDG harboring a novel de novo heterozygous frameshift variant (NM_005660.3: c.105_106insCG, p.K36Rfs*6). The patient presented with epileptic spasms, severe global developmental delay, hypotonia, and distinctive dysmorphic features including strabismus and inverted nipples. Notably, she exhibited bilateral patellar luxation and perineal dysmorphism with a shortened anogenital distance, features that have not been previously associated with SLC35A2-CDG. Additional findings included a thin corpus callosum, a pineal cyst, right-sided aortic arch, bilateral vesicoureteral reflux, and central hypothyroidism. Oral D-galactose supplementation was initiated and resulted in subjective improvements in language comprehension, pain responsiveness, and motor function, although no improvement in seizures was observed. Conclusions. This casa may expand the phenotypic spectrum of SLC35A2-CDG by describing bilateral patellar luxation and perineal dysmorphism as potentially novel clinical features, along with a previously unreported pathogenic variant. Recognition of such unique features is crucial for improving our clinical understanding of this rare disorder, guiding differential diagnosis, and contributing to a more refined characterization of genotype–phenotype correlations.
- 24 October 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (5) , 882-888
Open AccessPerineal dysmorphism and patellar luxation in SLC35A2-CDG: a new piece in the glycosylation puzzle
Background. Congenital disorders of glycosylation (CDG) represent a group of inherited metabolic diseases characterized by multisystem involvement. SLC35A2-CDG (OMIM #300896) is a rare X-linked subtype resulting from pathogenic variants in the SLC35A2 gene, which encodes the UDP-galactose transporter. Approximately 70 cases have been documented, predominantly presenting with early-onset epilepsy, developmental delay, hypotonia, and dysmorphic features. Phenotypic variability remains incompletely characterized, and novel features continue to expand the clinical spectrum. Case Presentation. We report a 6-year-old girl with SLC35A2-CDG harboring a novel de novo heterozygous frameshift variant (NM_005660.3: c.105_106insCG, p.K36Rfs*6). The patient presented with epileptic spasms, severe global developmental delay, hypotonia, and distinctive dysmorphic features including strabismus and inverted nipples. Notably, she exhibited bilateral patellar luxation and perineal dysmorphism with a shortened anogenital distance, features that have not been previously associated with SLC35A2-CDG. Additional findings included a thin corpus callosum, a pineal cyst, right-sided aortic arch, bilateral vesicoureteral reflux, and central hypothyroidism. Oral D-galactose supplementation was initiated and resulted in subjective improvements in language comprehension, pain responsiveness, and motor function, although no improvement in seizures was observed. Conclusions. This casa may expand the phenotypic spectrum of SLC35A2-CDG by describing bilateral patellar luxation and perineal dysmorphism as potentially novel clinical features, along with a previously unreported pathogenic variant. Recognition of such unique features is crucial for improving our clinical understanding of this rare disorder, guiding differential diagnosis, and contributing to a more refined characterization of genotype–phenotype correlations.
- 5 September 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Clinical relevance of seizure self-efficacy in pediatric epilepsy: Its associations with depression and anxiety
- 5 September 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Clinical relevance of seizure self-efficacy in pediatric epilepsy: Its associations with depression and anxiety
- Open Access
- 6 May 2026
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (7) , 1273-1277
WWOX Mutation as a Rare Cause of Neonatal‐Infantile Parkinsonism Mimicking a Neurotransmitter Disorder: A Case Report
Key Points: Neonatal‐onset parkinsonism is extremely rare and is most often attributed to monoamine neurotransmitter synthesis or metabolism disorders rather than to primary neurodevelopmental diseases. WWOX mutations should be considered in the differential diagnosis of neonatal hypokinetic–rigid syndromes, particularly when metabolic and neurotransmitter studies are normal. WWOX ‐related parkinsonian features likely reflect a developmental circuitopathy, characterized by impaired maturation and organization of dopaminergic and inhibitory networks rather than dopaminergic neuronal degeneration. Clinical differentiation between neurotransmitter disorders and WWOX ‐related parkinsonism is challenging, as both may present with neonatal rigidity, hypokinesia, hypotonia, abnormal movements, and seizures. Early comprehensive genetic testing is essential in neonates with parkinsonian features when standard metabolic investigations are unrevealing, as it may reveal rare but clinically relevant neurodevelopmental etiologies.
- 6 May 2026
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (7) , 1273-1277
Open AccessWWOX Mutation as a Rare Cause of Neonatal‐Infantile Parkinsonism Mimicking a Neurotransmitter Disorder: A Case Report
Key Points: Neonatal‐onset parkinsonism is extremely rare and is most often attributed to monoamine neurotransmitter synthesis or metabolism disorders rather than to primary neurodevelopmental diseases. WWOX mutations should be considered in the differential diagnosis of neonatal hypokinetic–rigid syndromes, particularly when metabolic and neurotransmitter studies are normal. WWOX ‐related parkinsonian features likely reflect a developmental circuitopathy, characterized by impaired maturation and organization of dopaminergic and inhibitory networks rather than dopaminergic neuronal degeneration. Clinical differentiation between neurotransmitter disorders and WWOX ‐related parkinsonism is challenging, as both may present with neonatal rigidity, hypokinesia, hypotonia, abnormal movements, and seizures. Early comprehensive genetic testing is essential in neonates with parkinsonian features when standard metabolic investigations are unrevealing, as it may reveal rare but clinically relevant neurodevelopmental etiologies.
- Open Access
- 11 March 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (2) , 1-7
Leber hereditary optic neuropathy (LHON) in a 6-year-old boy with a transient spinal cord lesion
Background. Leber hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that predominantly manifests as bilateral, painless vision loss in young males. While traditionally associated with the optic nerves, a subset of patients exhibits additional neurological symptoms, referred to as LHON-plus syndrome. Involvement of the spinal cord is uncommon, particularly among the pediatric population, and may result in diagnostic challenges, potentially leading to confusion regarding acquired demyelinating diseases. Case Presentation. We report a 6-year-old boy with near-complete vision loss in the right eye and blurred vision in the left eye. Demyelinating diseases were suspected in the case of acute bilateral optic neuropathy. Cranial and orbital magnetic resonance imaging (MRI) showed no demyelinating lesions, whereas spinal MRI revealed a T2-hyperintense lesion at the C3–C6 levels. Due to unresponsiveness to conventional treatment for demyelinating diseases, genetic testing confirmed the homoplasmic m.11778G>A variant in NADH dehydrogenase subunit 4 (MT-ND4), establishing an LHON diagnosis. Spinal cord involvement supported the LHON-plus syndrome classification. Idebenone therapy was initiated, and follow-up was scheduled. During the 1.5-year follow-up, right eye visual loss persisted, while the left eye showed gradual vision decline. A second spinal MRI performed at 6 months showed complete resolution of the previous lesion without new lesions. Conclusion. Since optic neuropathy and spinal cord involvement typically indicate demyelinating diseases, these should be prioritized in initial evaluation due to their frequency and need for early immunomodulatory treatment. However, spinal cord involvement can occur in mitochondrial diseases, as demonstrated in this case. The presence of a transient and asymptomatic spinal cord lesion in this patient expands the recognized spectrum of central nervous system involvement in LHON. Therefore, LHON-plus syndrome should be considered when spinal cord involvement accompanies optic neuropathy after excluding other demyelinating diseases.
- 11 March 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (2) , 1-7
Open AccessLeber hereditary optic neuropathy (LHON) in a 6-year-old boy with a transient spinal cord lesion
Background. Leber hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that predominantly manifests as bilateral, painless vision loss in young males. While traditionally associated with the optic nerves, a subset of patients exhibits additional neurological symptoms, referred to as LHON-plus syndrome. Involvement of the spinal cord is uncommon, particularly among the pediatric population, and may result in diagnostic challenges, potentially leading to confusion regarding acquired demyelinating diseases. Case Presentation. We report a 6-year-old boy with near-complete vision loss in the right eye and blurred vision in the left eye. Demyelinating diseases were suspected in the case of acute bilateral optic neuropathy. Cranial and orbital magnetic resonance imaging (MRI) showed no demyelinating lesions, whereas spinal MRI revealed a T2-hyperintense lesion at the C3–C6 levels. Due to unresponsiveness to conventional treatment for demyelinating diseases, genetic testing confirmed the homoplasmic m.11778G>A variant in NADH dehydrogenase subunit 4 (MT-ND4), establishing an LHON diagnosis. Spinal cord involvement supported the LHON-plus syndrome classification. Idebenone therapy was initiated, and follow-up was scheduled. During the 1.5-year follow-up, right eye visual loss persisted, while the left eye showed gradual vision decline. A second spinal MRI performed at 6 months showed complete resolution of the previous lesion without new lesions. Conclusion. Since optic neuropathy and spinal cord involvement typically indicate demyelinating diseases, these should be prioritized in initial evaluation due to their frequency and need for early immunomodulatory treatment. However, spinal cord involvement can occur in mitochondrial diseases, as demonstrated in this case. The presence of a transient and asymptomatic spinal cord lesion in this patient expands the recognized spectrum of central nervous system involvement in LHON. Therefore, LHON-plus syndrome should be considered when spinal cord involvement accompanies optic neuropathy after excluding other demyelinating diseases.
- 7 January 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1) , 15
A gentle and colorful touch of epilepsy surgery on a young painter’s art and life: a case report with dramatic paintings
Purpose Patients with drug-resistant epilepsy (DRE) may experience significant limitations in their activities of daily living, social interactions, educational processes, and cognitive and artistic abilities. Epilepsy surgery aims primarily to achieve seizure control with drug-resistant epilepsy (DRE), but it may also lead to improvements in quality of life, including cognitive, emotional, and psychosocial recovery. This report presents a 16-year-old patient with DRE who demonstrated a remarkable improvement in artistic and educational abilities following temporal lobe surgery, illustrating the multifaceted benefits of surgical treatment. Methods An adolescent male with DRE since the age of eight years, characterized by focal seizures of temporal lobe origin, was evaluated with video-EEG, brain MRI, and FDG-PET. The patient underwent right temporal lobectomy after confirming mesial temporal sclerosis. His psychosocial, educational, and artistic progress were followed for two years postoperatively. Results Following surgery, the patient achieved complete seizure freedom, progressive cognitive improvement, and significant emotional stabilization. His artistic abilities, once limited by the burden of frequent seizures, evolved dramatically, as reflected by increasingly sophisticated and colorful paintings. His educational performance improved, leading to his successful admission to the fine arts program of the university. Conclusion This case presentation, with its fascinating drawings and paintings, aims to highlight that epilepsy surgery in adolescents with DRE can offer benefits beyond seizure control. Restoration of cognitive and creative capacities can substantially improve quality of life, academic performance, and psychosocial well-being, underscoring the broader impact of surgical intervention in pediatric epilepsy.
- 7 January 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1) , 15
A gentle and colorful touch of epilepsy surgery on a young painter’s art and life: a case report with dramatic paintings
Purpose Patients with drug-resistant epilepsy (DRE) may experience significant limitations in their activities of daily living, social interactions, educational processes, and cognitive and artistic abilities. Epilepsy surgery aims primarily to achieve seizure control with drug-resistant epilepsy (DRE), but it may also lead to improvements in quality of life, including cognitive, emotional, and psychosocial recovery. This report presents a 16-year-old patient with DRE who demonstrated a remarkable improvement in artistic and educational abilities following temporal lobe surgery, illustrating the multifaceted benefits of surgical treatment. Methods An adolescent male with DRE since the age of eight years, characterized by focal seizures of temporal lobe origin, was evaluated with video-EEG, brain MRI, and FDG-PET. The patient underwent right temporal lobectomy after confirming mesial temporal sclerosis. His psychosocial, educational, and artistic progress were followed for two years postoperatively. Results Following surgery, the patient achieved complete seizure freedom, progressive cognitive improvement, and significant emotional stabilization. His artistic abilities, once limited by the burden of frequent seizures, evolved dramatically, as reflected by increasingly sophisticated and colorful paintings. His educational performance improved, leading to his successful admission to the fine arts program of the university. Conclusion This case presentation, with its fascinating drawings and paintings, aims to highlight that epilepsy surgery in adolescents with DRE can offer benefits beyond seizure control. Restoration of cognitive and creative capacities can substantially improve quality of life, academic performance, and psychosocial well-being, underscoring the broader impact of surgical intervention in pediatric epilepsy.
- Open Access
- 22 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (2) , 118-127
Molecular Spectrum and Deep Phenotyping of a Turkish Joubert Syndrome Cohort, Including a Potential Candidate Gene, NPHP4
Objective: Joubert syndrome (JS) is a rare neurodevelopmental ciliopathy defined by the molar tooth sign (MTS) on brain magnetic resonance imaging accompanied by hypotonia, oculomotor apraxia (OMA), developmental delay, and multisystem involvement. With over 40 genes implicated, JS displays genetic and phenotypic heterogeneity. This study aimed to define the clinical and molecular spectrum of JS in a Turkish cohort. Materials and Methods: This study included 31 JS patients from 28 unrelated families, followed for 7.4 years. Genetic variants were identified using whole exome sequencing and confirmed by Sanger sequencing. Results: Genetic diagnosis was established in 23 families in 13 JS-related genes, with AHI1 (17.9%) and CEP290 (14.3%) most frequently affected. Thirteen novel variants were identified, including a variant of uncertain significance in NPHP4 in a patient with OMA, retinal involvement, MTS, and grade-III vesicoureteral reflux (VUR). The MTS was absent in 2 AHI1 and atypical in 1 TMEM107 patient; others exhibited typical MTS. Ptosis occurred in all MKS1 and TCTN2 patients. Retinopathy and vision impairment were most common in AHI1 and CEP290. Cognitive outcomes varied; normal cognitive function was seen in 1 AHI1 and 1 CEP290 case. Renal/hepatic involvement was generally mild; kidney hypoplasia occurred in 1 AHI1, VUR in 1 NPHP4, and transient transaminase elevation in 1 TCTN2 patient. One patient without a genetic diagnosis had situs inversus totalis. Intra-familial variability occurred among siblings carrying an AHI1 variant. Conclusion: This study highlights the genotypic and phenotypic diversity of JS, identifying 13 novel variants and suggesting NPHP4 as a potential JS-associated gene.
- 22 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (2) , 118-127
Open AccessMolecular Spectrum and Deep Phenotyping of a Turkish Joubert Syndrome Cohort, Including a Potential Candidate Gene, NPHP4
Objective: Joubert syndrome (JS) is a rare neurodevelopmental ciliopathy defined by the molar tooth sign (MTS) on brain magnetic resonance imaging accompanied by hypotonia, oculomotor apraxia (OMA), developmental delay, and multisystem involvement. With over 40 genes implicated, JS displays genetic and phenotypic heterogeneity. This study aimed to define the clinical and molecular spectrum of JS in a Turkish cohort. Materials and Methods: This study included 31 JS patients from 28 unrelated families, followed for 7.4 years. Genetic variants were identified using whole exome sequencing and confirmed by Sanger sequencing. Results: Genetic diagnosis was established in 23 families in 13 JS-related genes, with AHI1 (17.9%) and CEP290 (14.3%) most frequently affected. Thirteen novel variants were identified, including a variant of uncertain significance in NPHP4 in a patient with OMA, retinal involvement, MTS, and grade-III vesicoureteral reflux (VUR). The MTS was absent in 2 AHI1 and atypical in 1 TMEM107 patient; others exhibited typical MTS. Ptosis occurred in all MKS1 and TCTN2 patients. Retinopathy and vision impairment were most common in AHI1 and CEP290. Cognitive outcomes varied; normal cognitive function was seen in 1 AHI1 and 1 CEP290 case. Renal/hepatic involvement was generally mild; kidney hypoplasia occurred in 1 AHI1, VUR in 1 NPHP4, and transient transaminase elevation in 1 TCTN2 patient. One patient without a genetic diagnosis had situs inversus totalis. Intra-familial variability occurred among siblings carrying an AHI1 variant. Conclusion: This study highlights the genotypic and phenotypic diversity of JS, identifying 13 novel variants and suggesting NPHP4 as a potential JS-associated gene.
- 17 April 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 130, 1-3
Phenotypic similarities and differences between SLC6A1-related neurodevelopmental disorder and GLUT1 deficiency syndrome
- 17 April 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 130, 1-3
Phenotypic similarities and differences between SLC6A1-related neurodevelopmental disorder and GLUT1 deficiency syndrome
- Open Access
- 2 January 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (1) , 106-107
Diagnosis of Congenital Cytomegalovirus in a 14-Month-Old Patient Presenting with Sensorineural Hearing Loss: Storing Dry Blood Samples
Cite this article as: Anıl G, Gökçe C, Ayfer SG, Leman TO, Murat S, Bülent K. Diagnosis of congenital CMV in a 14-month-old patient presenting with sensorineural hearing loss: storing dry blood samples. Turk Arch Pediatr. 2025;60(1):106-107.
- 2 January 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (1) , 106-107
Open AccessDiagnosis of Congenital Cytomegalovirus in a 14-Month-Old Patient Presenting with Sensorineural Hearing Loss: Storing Dry Blood Samples
Cite this article as: Anıl G, Gökçe C, Ayfer SG, Leman TO, Murat S, Bülent K. Diagnosis of congenital CMV in a 14-month-old patient presenting with sensorineural hearing loss: storing dry blood samples. Turk Arch Pediatr. 2025;60(1):106-107.
- 20 October 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 150, 32-36
Children With Type 1 Spinal Muscular Atrophy Are at Increased Risk for Nephrolithiasis
- 20 October 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 150, 32-36
Children With Type 1 Spinal Muscular Atrophy Are at Increased Risk for Nephrolithiasis